Promega builds plant to produce regulated products

Published: 29-Aug-2011
Manufacturing Analysis

Including sample preparation systems and reagents

Promega Corporation, based in Madison, Wisconsin, US, has held a ground-breaking ceremony for a new cGMP facility to support business growth and customers who need FDA-regulated molecular biology products. These include sample preparation systems and reagents, which are part of diagnostic and medical tests sold by human diagnostic test providers.

The 260,000ft2 (24,150m2) facility will require an additional 100 people in the next five years. Most of the building will be dedicated to fixed and flexible manufacturing areas. It will also house a customer experience centre for training, laboratory demonstrations and conferences.

‘This building is our next step in expanding our product supply capabilities worldwide,’ said ceo Bill Linton.

Plans include a number of sustainable practices, including geothermal heating and cooling, dark sky compliant lighting, prairie restoration, bio-retention ponds for storm water run off among other sustainable features and construction practices.

Promega Corporation provides solutions and technical support to the life sciences industry. Its 2,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification.

See more

You may also like

Manufacturing

Promega opens new Shanghai facility

Read more
Provides additional r&d and cGMP manufacturing capabilities

Trending Articles

  1. Ultra-high potency and its impact on pharmaceutical outsourcing This article explores the emerging distinction between high and ultra-high potency APIs, highlighting the implications for pharmaceutical outsourcing and risk management in an evolving therapeutic landscape
  2. Clarivate releases Drugs to Watch 2026 report The report features 11 breakthrough therapies shaping obesity, women's health, rare disease care and oncology innovation from companies such as Eli Lilly and GSK
  3. Dual stage degasser vacuum pump from Biotech Fluidics Biotech Fluidics has introduced a durable dual stage moulded vacuum pump designed to improve your fluidic degassing experience
  4. Piramal Pharma Solutionsd demonstrates commitment to excellence with net promoter score Piramal Pharma Solutions recently achieved a net promoter score (NPS) of 55, far surpassing industry averages
  5. LYOVAC® ECO Mode: making pharmaceutical freeze-drying leaner and greener Following the recent announcement that GEA Lyophil has received third-party certification for the energy-saving credentials of its innovative algorithm for freeze-drying applications, Dr Kevin Robinson caught up with Senior Director of Lyophilization Technology Management, Thomas Beutler, to find out more

Upcoming event

From powder to granules: a deep dive into wet granulation methods

14 January 2026 | Virtual See all

You may also like

Manufacturing

Promega opens new Shanghai facility

Provides additional r&d and cGMP manufacturing capabilities
Manufacturing

Two decades of safe drying and storage solutions from SICCO

In the UK, Labtex supply the full spectrum of SICCO desiccators, drying cabinets and glove boxes for use in demanding industrial sectors
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Miniaturisation in medtech: mechanical factors that influence product success

Medical devices are becoming smaller, lighter and more portable. From handheld diagnostic tools to wearable infusion pumps and compact surgical instruments, reduced size is now a defining feature of many new medtech products
Manufacturing

MedPharm completes FDA inspection of manufacturing plant in Durham

The topical drug product manufacturing facility in North Carolina successfully completed its FDA inspection for the commercial manufacture of drug products with no Form 483 issued plus an NAI classification
Manufacturing

Sharp Sterile Manufacturing invests $28m into US sterile fill-finish site

The investment will more than double the existing Massachusetts site's filling capacity, strengthening Sharp's long-term commitment to US-based sterile drug production
Manufacturing

New thermal inkjet printer expands AM Labels’ coding portfolio

M2 system delivers high resolution variable data printing at production-line speeds
Manufacturing

Autolus to evaluate Cellares' automated Cell Shuttle platform for scalable CAR T manufacturing

Autolus Therapeutics will assess Cellares’ fully automated Cell Shuttle manufacturing platform as a potential complement to its Nucleus facility in Stevenage, supporting future scale-up of AUCATZYL (obe-cel) as the therapy advances into new oncology and autoimmune indications
Subscribe now